According to Nuvectis Pharma's latest financial reports the company's current EPS (TTM) is -HK$12.07. In 2022 the company made an earnings per share (EPS) of -HK$11.68 a decrease over its 2021 EPS that were of -HK$8.22.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$12.15 | 3.98% |
2022 | -HK$11.68 | 42.18% |
2021 | -HK$8.22 |